A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

Conditions: Non-segmental Vitiligo Interventions: Biological: MK-6194; Drug: Placebo Sponsors: Merck Sharp& Dohme LLC Not yet recruiting

Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials